Ankerstar Wealth’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67K Hold
30
– – ﹤0.01% 441
2026
Q2
$1.65K Hold
30
– – ﹤0.01% 411
2026
Q1
$997 Buy
30
+10
+50% +$298 ﹤0.01% 454
2025
Q4
$596 Buy
+20
New +$653 ﹤0.01% 603

Other funds holding TGTX

Ankerstar Wealth's TGTX Position: Q3 2026 in Review

Ankerstar Wealth held its TG Therapeutics (TGTX) position steady in Q3 2026 at 30 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Ankerstar Wealth first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Ankerstar Wealth held 30 shares of TG Therapeutics worth $1.67K as of Q3 2026.
  • Ankerstar Wealth left its TG Therapeutics share count unchanged in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #441 holding.
  • Ankerstar Wealth first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.